Uniting Medically Supervised Injecting Centre
An Australian medically supervised injecting centre providing sterile equipment, clinical oversight and harm-reduction support in Kings Cross, Sydney.
Last updated November 4, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
The Uniting Medically Supervised Injecting Centre, commonly called Uniting MSIC or the Sydney Medically Supervised Injecting Centre, is a state-supported harm-reduction and healthcare facility in Kings Cross, Sydney. It provides a legally supervised setting in which adults who have previously injected drugs can consume illicit substances intravenously under the observation of trained staff. The centre supplies sterile injecting equipment and water, responds to overdoses and other medical emergencies, and offers health advice, basic clinical care, counselling and referrals to treatment and social-support services. The facility emerged from Sydney's long-running public-health and public-order problems associated with heroin use, homelessness, street injecting and the concentration of drug markets in Kings Cross. During the 1990s, some privately operated and illicitly tolerated “shooting galleries” provided users with secluded spaces and rudimentary safety measures. The closure of many of these venues following the Wood Royal Commission into police corruption helped intensify debate over whether a regulated public-health alternative should be established. After several years of parliamentary and community discussion, the New South Wales Parliament authorized an 18-month supervised-injecting trial in 1999. The original proposal was associated with the Sisters of Charity Health Service, which later withdrew. The New South Wales Government subsequently invited the Uniting Church of Australia to operate the facility. Kings Cross was selected because of the concentration of drug use and overdose risk in the area, while the chosen site was positioned away from many shops, clubs and pubs. The centre opened at 66 Darlinghurst Road on 6 May 2001, becoming Australia's first legally sanctioned injecting facility. Its operation is governed by provisions inserted into Part 2A of the New South Wales Drug Misuse and Trafficking Act 1985. These provisions establish licensing and supervision requirements, define staff and training obligations, and provide specific legal protections for clients using the service. The trial was extended in 2002, 2003 and 2007. Following longitudinal evaluations, including work commissioned from KPMG and other independent bodies, the New South Wales Parliament removed the trial designation in 2010 and authorized the centre to operate on a permanent basis. The service is organized around registration and assessment, supervised injecting and post-consumption aftercare. Staff assess a client's health history and intended drug use, explain risks and provide sterile supplies. In the injecting area, nurses and other trained personnel can respond to overdose using oxygen and naloxone. Clients may then remain in an aftercare area until they are sufficiently stable to leave. The centre also provides vein-care advice, health promotion, sexual-health and nutrition information, and referrals to drug-treatment programs, hospitals, housing services, mental-health care, social services and legal assistance. Mental-health nursing was added in 2012, and the centre has participated in research, clinical trials and overdose-response training for professionals, students and local businesses. Available evaluations have reported substantial harm-reduction effects. By 2016, the centre had supervised more than one million injections without a recorded fatality. Research has also associated its operation with fewer public injections, reduced discarded needles in the surrounding area and lower demand for emergency ambulance services in Kings Cross. The centre's role remains controversial: opponents have argued that it normalizes or encourages drug use, attracts users to the area and is insufficiently used by people at the greatest risk. Supporters and independent evaluations have generally found no demonstrated increase in local crime or blood-borne-virus diagnoses attributable to the facility. Its continuing operation reflects Australia's broader public-health debate over supervised consumption, treatment access and the management of public drug use.
History
Sydney's Kings Cross became a significant centre of heroin availability and consumption from the 1970s onward. The suburb's drug market intersected with homelessness, sex work and nightlife, creating recurring public-health and public-order problems. During the 1990s, illicitly operated shooting galleries offered drug users private rooms in which to inject, sometimes with clean equipment and employees capable of responding to an overdose. Although these premises were not legal medically supervised facilities, their existence demonstrated demand for a controlled environment away from public streets. The 1997 Wood Royal Commission into police corruption in New South Wales exposed the extent to which some shooting galleries had operated with official tolerance or limited enforcement. Many subsequently closed. The closures contributed to renewed consideration of a lawful, clinically supervised alternative that could address overdose and unsafe injecting without endorsing the supply or possession of illicit drugs. Between 1996 and 1999, the proposal for a supervised injecting centre was the subject of sustained public, political and parliamentary debate. The Sisters of Charity Health Service initially secured the proposal but withdrew after opposition from the Vatican. The New South Wales Government then asked the Uniting Church of Australia to oversee the project. Kings Cross was selected because it had a high concentration of drug use and overdose activity, as well as local support from residents and government representatives. The chosen premises at 66 Darlinghurst Road were close to areas where drugs were bought and used but were separated from many mainstream retail, club and pub locations. The New South Wales Parliament passed legislation in 1999 authorizing an 18-month trial. The Uniting Medically Supervised Injecting Centre opened on 6 May 2001. It was Australia's first legal facility established specifically to supervise the injection of illicit drugs. Its legal framework was created through amendments to Part 2A of the Drug Misuse and Trafficking Act 1985. The framework sets standards for licensing, clinical supervision and staff training and provides defined exemptions and enforcement discretion for eligible clients using or travelling to and from the service. The trial was extended in 2002, 2003 and 2007. Debate continued because critics questioned whether the centre reduced harm or instead encouraged drug use and concentrated users in Kings Cross. Independent assessments, including evaluations associated with KPMG and public-health research bodies, reported evidence of reduced public injecting, emergency intervention and discarded syringe counts without a demonstrated increase in local crime attributable to the facility. On 1 November 2010, the New South Wales Parliament passed legislation removing the trial status and permitting permanent operation. The centre's model uses three main areas: reception and assessment, supervised injecting, and aftercare. Eligible clients must be adults, have injected drugs previously, not be accompanied by a child and not already be intoxicated. Staff assess health history and intended drug use, explain risks and supply sterile equipment. Registered nurses and other trained personnel supervise the injection process and can administer oxygen and naloxone during an overdose. Clients can recover in the aftercare area before leaving through a separate exit. The centre has supervised use of drugs including heroin, cocaine, methamphetamines and prescription opioids such as oxycodone and morphine. Its broader service includes basic medical assessment, vein care, safer-injecting education, sexual-health information, nutrition and liver-health advice. Staff may refer clients to detoxification and other drug-treatment programs, hospitals, mental-health services, housing providers, social services and legal centres. Mental-health nursing was introduced in 2012. The facility has also served as a site for research and medical trials involving drug users and has provided overdose and harm-reduction training to health professionals, students and local businesses. Reported outcomes include more than one million supervised injections by 2016 without a recorded fatality inside the centre. Research cited in the facility's historical accounts found that many clients would otherwise have injected in public and that the centre generated substantial referrals to treatment and other care. Early studies also reported a large reduction in ambulance call-outs in Kings Cross and a decline in publicly discarded needles and syringes. Available accounts state that local crime patterns and diagnoses of HIV, hepatitis B and hepatitis C did not show changes that could be attributed to the centre. Despite continuing criticism from politicians, media outlets and Drug Free Australia, the service remains an important Australian example of supervised consumption within a public-health framework.
- 2016
One million supervised injections
[1]The centre reported supervising more than one million injections since opening without a recorded fatality on site.
- 2012
Mental-health nursing introduced
[1]The centre added mental-health nurses to extend support for clients with psychiatric and related needs.
- 2010
Permanent legal authorization
[1]Legislation passed on 1 November 2010 removed the trial designation and authorized permanent operation.
- 2007
Third trial extension
[1]The centre's trial status was extended again pending further evidence and parliamentary consideration.
- 2003
Second trial extension
[1]New South Wales extended the supervised-injecting trial for a further period.
- 2002
First trial extension
[1]The operating trial was extended while the centre's health and community effects continued to be evaluated.
- 2001
Uniting MSIC opens
[1]The centre began operating in Kings Cross on 6 May 2001 as Australia's first legal injecting facility.
- 1999
New South Wales authorizes an 18-month trial
[1]Parliament approved legislation allowing a medically supervised injecting centre to operate on a trial basis.
- 1997
Wood Royal Commission highlights the shooting-gallery context
[1]The New South Wales police-corruption inquiry drew attention to illicit shooting galleries in Kings Cross and helped renew debate about regulated supervised injecting services.
Products and positioning
A regulated, healthcare-led harm-reduction service intended to prevent fatal overdose, infectious disease, injection-related injury and public injecting while connecting marginalized drug users with treatment and support.
Harm-reduction healthcare service · 2001
Medically supervised injecting
The centre provides an indoor, supervised setting for eligible adults who have previously injected drugs. Clients receive an assessment before entering the injecting area, where trained nurses and other staff monitor them and can intervene in the event of overdose or acute medical distress. The service is designed to reduce unsafe public injecting and provide a point of contact with healthcare and social services.
Preventive health service · 2001
Sterile injecting equipment
Uniting MSIC supplies sterile equipment and water for clients using the supervised injecting area. The service supports safer injecting practices and helps reduce risks associated with contaminated equipment, injection-related injury and blood-borne infection. Staff also provide practical education on safer technique and can advise on vein care and other immediate health concerns.
Emergency and post-consumption care · 2001
Overdose response and aftercare
Staff monitor clients during and after injection and are trained to respond to overdose with oxygen and naloxone. After consuming a drug, clients can remain in a separate aftercare area under staff support until they are ready to leave. This arrangement allows medical problems to be identified earlier than they might be in an unsupervised public setting.
Integrated support service · 2001
Counselling, education and referrals
The centre combines routine harm-reduction conversations with counselling and referrals. Topics can include overdose prevention, sexual health, nutrition, liver health and safer injecting. Depending on a client's needs, staff may connect them with drug-treatment programs, hospitals, mental-health services, housing assistance, social services or legal support.
Controversies
Incorrect report about discarded syringes
An early media report alleged that syringes from the centre had been negligently discarded in public bins behind the facility. The items were later identified as syringes associated with a neighbouring property's diabetic cat, and the report was corrected.
Marketing campaigns
- 2012Expanded mental-health support
Sydney · Australia
Uniting MSIC expanded its harm-reduction offer by adding mental-health nurses and increasing the range of support available to clients.
Outcome. The centre became a more integrated access point for clients requiring mental-health assistance as well as injecting supervision.
- 2001Kings Cross supervised-injecting trial
New South Wales · Australia
The centre's opening implemented the New South Wales Government's supervised-injecting trial and established a regulated harm-reduction model in Kings Cross.
Outcome. The trial was extended several times and later converted into a permanent legal service in 2010.
- Overdose-response and harm-reduction training
Sydney · Australia
The centre has provided harm-reduction and overdose-response training for healthcare professionals, students and interested local businesses.
Outcome. The training extended the centre's educational role beyond its registered client base.
Brand decisions
2012
Broaden the service to include mental-health nursingStrategyBackground
Client needs extended beyond injection supervision to include mental-health conditions and related social vulnerabilities.
Action taken
The centre began employing mental-health nurses.
Aftermath
Mental-health support became part of the centre's wider integrated healthcare and referral model.
2010
Convert the trial into a permanent serviceStrategyBackground
Independent evaluations and longitudinal evidence were cited in the parliamentary assessment of the centre's health and community effects.
Action taken
Legislation passed on 1 November 2010 to remove the trial designation and provide a permanent operating licence.
Aftermath
Uniting MSIC continued as a permanent legally authorized harm-reduction facility in New South Wales.
1999
Proceed with a supervised-injecting trialStrategyBackground
Kings Cross faced concentrated drug use, overdose risk, homelessness and public injecting, while public debate considered whether a regulated health service could reduce harm.
Action taken
The New South Wales Parliament authorized an 18-month trial of a medically supervised injecting centre.
Aftermath
The trial led to the opening of Uniting MSIC in 2001 and was subsequently extended three times.
Recent events
- 2016
Centre reports more than one million supervised injections without a recorded fatality[1]
Other
By 2016, the centre had supervised over one million injections since opening, with no recorded fatal overdose death inside the facility.
- 2012
Mental-health nursing service added[1]
Product launch
The centre expanded its clinical offer by employing mental-health nurses to support clients with a broad range of mental-health needs.
- 2010
Parliament makes Uniting MSIC permanent[1]
Regulation
Following successive extensions and evidence from independent evaluations, legislation passed on 1 November 2010 to give the centre a permanent legal operating licence.
- 2002
New South Wales extends the supervised-injecting trial[1]
Regulation
The New South Wales Government extended the centre's initial trial, allowing supervised services to continue while evaluations and public debate proceeded.
- 2001
Uniting Medically Supervised Injecting Centre opens in Kings Cross[1]
Product launch
The facility opened at 66 Darlinghurst Road on 6 May 2001 as Australia's first legally authorized medically supervised injecting centre.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/uniting-medically-supervised-injecting-centre · Editorial policy · How profiles are compiled